Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Lantern Pharma Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q1 2021
- Shares held
- 1.35M
- −56.8K (−4.0%) vs. Q1 2021
- Total value
- $19.7M
- −$5.80M (−22.8%) vs. Q1 2021
- New holders
- 3
- 13 more added
- Sold out
- 5
- 2 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LTRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $12.0M |
| Q1 2026 | 33 | $2.87M |
| Q4 2025 | 33 | $6.91M |
| Q3 2025 | 30 | $9.89M |
| Q2 2025 | 35 | $7.11M |
| Q1 2025 | 32 | $8.62M |
| Q4 2024 | 32 | $8.00M |
| Q3 2024 | 31 | $4.90M |
| Q2 2024 | 39 | $6.01M |
| Q1 2024 | 34 | $9.75M |
| Q4 2023 | 30 | $4.94M |
| Q3 2023 | 27 | $3.93M |
| Q2 2023 | 25 | $6.50M |
| Q1 2023 | 21 | $5.23M |
| Q4 2022 | 23 | $5.40M |
| Q3 2022 | 26 | $6.84M |
| Q2 2022 | 26 | $8.06M |
| Q1 2022 | 25 | $10.4M |
| Q4 2021 | 33 | $13.1M |
| Q3 2021 | 25 | $15.7M |
| Q2 2021 | 22 | $19.7M |
| Q1 2021 | 24 | $25.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Lantern Pharma Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Corriente Advisors, LLC | 656,364 | $9.58M | 5.17% | −57,442−8.0% | Reduced |
| Vanguard Group Inc | 269,429 | $3.93M | 0.00% | +10,282+4.0% | Added |
| GWM Advisors LLC | 151,316 | $2.21M | 0.06% | +151,316 | New |
| Geode Capital Management, LLC | 55,479 | $809.0K | 0.00% | +9,649+21.1% | Added |
| Morgan Stanley | 52,304 | $764.0K | 0.00% | +1,602+3.2% | Added |
| Redmond Asset Management, LLC | 45,500 | $664.0K | 0.19% | +509+1.1% | Added |
| Wolff Wiese Magana LLC | 28,319 | $413.0K | 0.29% | +1,244+4.6% | Added |
| Bank of New York Mellon Corp | 26,765 | $391.0K | 0.00% | +14,990+127.3% | Added |
| BlackRock Inc. | 25,117 | $366.0K | 0.00% | +1,467+6.2% | Added |
| Northern Trust Corp | 12,629 | $184.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 8,244 | $121.0K | 0.00% | +6,078+280.6% | Added |
| Wells Fargo & Company | 7,423 | $109.0K | 0.00% | +3,780+103.8% | Added |
| Bank of America Corp | 2,191 | $32.0K | 0.00% | +2,151+5,377.5% | Added |
| US Bancorp | 2,000 | $29.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $15.0K | 0.00% | −300−23.1% | Reduced |
| Spire Wealth Management | 1,050 | $15.0K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 1,027 | $15.0K | 0.00% | +27+2.7% | Added |
| Tower Research Capital LLC (TRC) | 352 | $5.00K | 0.00% | +290+467.7% | Added |
| Steward Partners Investment Advisory, LLC | 250 | $4.00K | 0.00% | +250 | New |
| Harbour Investments, Inc. | 45 | $1.00K | 0.00% | +2+4.7% | Added |
| Royal Bank of Canada | 13 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $0 | 0.00% | +1 | New |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −147,671−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −42,106−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,192−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Mesirow Financial Investment Management, Inc. | 0 | $0 | 0.00% | −818−100.0% | Sold out |